Ecstasy-for-Medication Advocate Raises $100 Million

The Multidisciplinary Affiliation for Psychedelic Research, a nonprofit chief within the pharmaceutical psychedelics trade, has raised greater than $100 million in a Collection A non-public inventory sale.  

MAPS wanted the cash to fund the ultimate levels of its utility for regulatory approval to promote MDMA, also referred to as Ecstasy, to deal with post-traumatic stress dysfunction, the group stated in an announcement Friday.